Brief: Biomed Lublin Signs Cooperation Agreement With Bioton
Feb 12 (Reuters) - BIOMED LUBLIN BML.WA :
* SIGNS COOPERATION AGREEMENT WITH BIOTON SA BIOP.WA ON MARKETING CO'S PRODUCT DISTREPTAZA
* UNDER DEAL CO TO SELL DISTREPTAZA EXCLUSIVELY TO BIOTON, DEAL WILL LAST TILL END OF 2022
* CO TO PAY BIOTON REMUNERATION FOR ITS SERVICES OF PRODUCT PROMOTION DEPENDING ON VOLUMES
SOLD
Source text for Eikon: ID:nEM7VrZJa
Further companies coverage: BML.WA , BIOP.WA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Bioton SA
See all newsBrief: Bioton Q1 Net Loss At 5.2 Million Zlotys
Brief: Bioton Says Polish Court Declares Chinese Arbitral Award Enforceable
Brief: Bioton SA - FY Net Profit At 3.4 Million Zlotys
Brief: Bioton EGM To Vote On Reducing Share Capital To About 8.59 Mln Zlotys From About 1.72 Bln Zlotys
Brief: Bioton Q4 Net Profit At 1.8 Mln Zlotys